Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow (Q40117676)

17 September 2017

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow (English)

1 reference

17 September 2017

0 references

1 reference

13

John C Bell

1 reference

17 September 2017

7

David F Stojdl

1 reference

17 September 2017

3

Chantal G Lemay

1 reference

17 September 2017

Caroline J Breitbach

1

1 reference

17 September 2017

Jennifer M Paterson

2

1 reference

17 September 2017

Theresa J Falls

4

1 reference

17 September 2017

Allison McGuire

5

1 reference

17 September 2017

Kelley A Parato

6

1 reference

17 September 2017

Manijeh Daneshmand

8

1 reference

17 September 2017

Kelly Speth

9

1 reference

17 September 2017

David Kirn

10

1 reference

17 September 2017

J Andrea McCart

11

1 reference

17 September 2017

Harold Atkins

12

1 reference

17 September 2017

19 June 2007

1 reference

17 September 2017

1 reference

17 September 2017

15

1 reference

17 September 2017

9

1 reference

17 September 2017

1686-1693

1 reference

Recent progress in the battle between oncolytic viruses and tumours

17 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Getting oncolytic virus therapies off the ground

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Oncolytic viruses as novel anticancer agents: turning one scourge against another

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Liver bypass significantly increases the transduction efficiency of recombinant adenoviral vectors in the lung, intestine, and kidney

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Adenovirus type 5 interactions with human blood cells may compromise systemic delivery.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

The effect of hypoxia on the uptake, replication and lytic potential of group B adenovirus type 3 (Ad3) and type 11p (Ad11p).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

The relationship between extracellular lactate and tumour pH in a murine tumour model of ischaemia-reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Blood clearance rates of adenovirus type 5 in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Analysis of adenovirus sequestration in the liver, transduction of hepatic cells, and innate toxicity after injection of fiber-modified vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Angiogenesis monitored by perfusion with a space-filling microbead suspension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug delivery.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Neutrophils and immunity: challenges and opportunities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Vascular ischaemia and reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Postischemic leukocyte/endothelial cell interactions and microvascular barrier dysfunction in skeletal muscle: cellular mechanisms and effect of Daflon 500 mg.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Unique structural features that influence neutrophil emigration into the lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Openings between defective endothelial cells explain tumor vessel leakiness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Solid tumors "melt" from the inside after successful CD8 T cell attack

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Carrier cell-based delivery of an oncolytic virus circumvents antiviral immunity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Different host-cell shutoff strategies related to the matrix protein lead to persistence of vesicular stomatitis virus mutants on fibroblast cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300215

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300215

1 reference

17 September 2017

1 reference